Research Update: MultiPlan Inc.'s $315 Million Senior Secured Term Loan Rated 'B+'; Other Ratings Affirmed; Outlook Remains Stable Mar 10

  • ID: 1869321
  • March 2010
  • Standard & Poors
1 of 3

U.S. health care cost-management provider MultiPlan Inc. is planning to issue a $315 million incremental term loan (due in April 2013) under its existing senior secured credit facilities. MultiPlan will use proceeds from the incremental term loan primarily for financing its pending acquisition of Viant Holdings Inc. (B/Watch Pos/--). The company has recently received regulatory approval for this acquisition. We are assigning our 'B+' issue rating and '3' recovery rating on MultiPlan's proposed $315 million incremental term loan. We are affirming all of our ratings on MultiPlan, including the 'B+' counterparty credit rating. The outlook remains stable. On March 5, 2010, Standard & Poor's Ratings Services assigned its 'B+' issue-level rating on MultiPlan Inc.'s planned $315 million senior secured incremental...

Companies mentioned in this report are:
- MultiPlan Inc.
- Viant Holdings Inc. (dba Viant)

Action: Affirmed
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress READ MORE >

Note: Product cover images may vary from those shown
2 of 3

- MultiPlan Inc.
- Viant Holdings Inc. (dba Viant)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.